Teladoc Health Inc (NYSE:TDOC) price on Wednesday, November 13, fall -1.34% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $9.57.
A look at the stock’s price movement, the close in the last trading session was $9.70, moving within a range at $9.42 and $10.1. The beta value (5-Year monthly) was 0.9. Turning to its 52-week performance, $22.54 and $6.76 were the 52-week high and 52-week low respectively. Overall, TDOC moved 0.63% over the past month.
Teladoc Health Inc’s market cap currently stands at around $1.65 billion, with investors looking forward to this quarter’s earnings report slated for in December.
Analysts have a consensus estimate of 640.47M for the company’s revenue for the quarter, with a low and high estimate of 632.34M and 673.8M respectively. The average forecast suggests down to a -3.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.57B, representing a -1.30% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TDOC is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
19 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 10 analyst(s) rate the stock as a Hold, 9 recommend TDOC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TDOC’s current price about 4.04% and 8.32% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.21, while 7-day volatility ratio is 5.90% and 6.47% in the 30-day chart. Further, Teladoc Health Inc (TDOC) has a beta value of 0.90, and an average true range (ATR) of 0.59. Analysts have given the company’s stock an average 52-week price target of $36, forecast between a low of $9 and high of $150. Looking at the price targets, the low is 5.96% off current price level while to achieve the yearly target high, price needs to move -1467.4%. Nonetheless, investors will most likely welcome a -276.18% jump to $36 which is the analysts’ median price.
If we refocus on Teladoc Health Inc (NYSE:TDOC), historical trading data shows that trading volumes averaged 7.53 over the past 10 days and 5.48 million over the past 3 months. The company’s latest data on shares outstanding shows there are 172.17 million shares.
The 1.56% of Teladoc Health Inc’s shares are in the hands of company insiders while institutional holders own 75.18% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 26.93 million on 2024-10-31, giving us a short ratio of 5.58. The data shows that as of 2024-10-31 short interest in Teladoc Health Inc (TDOC) stood at 2029.0 of shares outstanding, with shares short falling to 27.64 million registered in 2024-09-30. Current price change has pushed the stock -55.59% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TDOC stock continues to rise going into the next quarter.
